Navigation Links


Peregrine at Biology News

Peregrine at Biology Products
Peregrine at Biology Technology
Peregrine at Medicine News

Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, today announced initiation of a new clinical trial designed to evaluate the safety and efficacy of its tumor necrosis therapy (TNT) agent Cotara(R) in patients with glioblastoma multiforme (GBM), a deadly...
Peregrine at Medicine Products
Peregrine at Medicine Technology

Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients

- 50% of All Evaluable Patients Receiving Combination ofBavituximab Plus Chemotherapy Achieved ObjectiveTumor Response or Stable Disease - - 75% of Patients Receiving Combination ofBavituximab Plus Gemcitabine Achieved Objective Tumor Response or Stable Disease - - 50% ofPatients Receiving Combination of Bavituximab Plus...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - Affitech AS, thehuman antibody therapeutics company announced today that PeregrinePharmaceuticals, Inc. reported positive in vivo test results of R3,a fully human monoclonal antibody developed by Affitech, in apancreatic cancer model at the recently concluded Centennial AnnualMeeting of the American Association for Cancer Research (AACR). R3has...

Peregrine Pharmaceuticals Highlights Significant Advances in the Company's Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting

- New Study Demonstrated the Clinical Potential of Peregrine'sUnique Selective Anti-VEGF Antibodies, Which Were as Effective asAvastin(R) in Animal Cancer Models TUSTIN, Calif., April 20, 2007 /PRNewswire-FirstCall/ --Peregrine Pharmaceuticals, Inc. , a clinical stagebiopharmaceutical company developing targeted monoclonal antibodiesfor the treatment of cancer and hepatitis C virus infect...

Data Presented at AACR Meeting Shows Peregrine's Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies

- New Studies Confirm That Fusion Proteins Made by CombiningCytokines With Peregrine's Anti-PS Antibodies Demonstrate IncreasedAnti-Tumor Activity With No Observable Toxicity - LOS ANGELES and TUSTIN, Calif., April 18, 2007/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , aclinical stage biopharmaceutical company developing targetedmonoclonal antibodies for the treatment of canc...

Data Presented at AACR Meeting Show Peregrine's Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer

--Immunization with a Bavituximab Equivalent and Irradiated TumorCells Increased Long-Term Survival to 57% From 0% in Controls in aPreclinical Model of Brain Cancer-- LOS ANGELES and TUSTIN, Calif., April 18, 2007/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , aclinical stage biopharmaceutical company developing targetedmonoclonal antibodies for the treatment of cancer and hep...

More>>

Other TagshERG
(Date:8/20/2008)...vement Law immediately affects the operations of...ies nationwide, POR...e and Senate,overrode President Bush,s veto of HR ... beneficiaries, they also established stricter,req...of the busiest months,of the year for that industr...
(Date:8/20/2008)... to illegally sell alcohol, study finds , ...re a minor or already drunk, many vendors in Ameri...eer or other alcoholic beverage. , That,s the f...n,t doing enough to keep booze away from those who... underage were able to buy alcohol 18 percent of t...
(Date:8/20/2008)... Fourteen physicians who have been,part of Commonw...to enhance,the care and service they provide to th...se are top-notch primary care physicians, and we a...ation," said Nick Turkal, M.D., Aurora,s,president...working with,them to support their care of patient...
(Date:8/20/2008)...rth is part of a new generation of neurosurgeons w...ts. , At Loyola University Hospital, Duckworth i... to repair life-threatening aneurysms and to drama...Rather than removing large sections of the skull o...ch smaller openings. And in certain cases, he goes...
Breaking Medicine News(10 mins):Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Underaged, Inebriated Easily Get Drinks at Stadiums 2Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2Health News:Brain surgery is getting easier on patients 2Health News:Brain surgery is getting easier on patients 3
(Date:8/20/2008)...n? How about a strawberry-flavored banana? Biochem...Houston say the day may be coming when scientists ...flavors in fruits and vegetables. In addition, it ...l. , In the advance online publication of Natur...or C.S. Raman, Ph.D., and his colleagues report th...
(Date:8/20/2008)...oday, the U.S. Environmental Protection Agency (EP...e University of Kentucky (UK) to investigate how t...ability to enter the brain. This is the largest E...arded to the University of Kentucky as well as the... nanotechnology research. , "Nanotechnology is ...
(Date:8/20/2008)...he contrary, early humans evolved not as aggressiv...ans are no more born to be hunters than to be gard... of anthropology at Washington University in St. L...rsial book "Man the Hunted: Primates, Predators an...sed in July by Westview Press, includes a new chap...
(Date:8/20/2008)... tide algae, Karenia brevis, costs approximately $...ast of Florida alone. Scientists at the Georgia In... reduce the levels of the red tide,s toxicity to a...e,s toxicity to other algae as well. If scientists...ity of red tide, they could reduce the vast amount...
Breaking Biology News(10 mins):Biochemists manipulate fruit flavor enzymes 2$2M grant awarded to University of Kentucky for research on nanoparticles and human health 2New book further supports controversial theory of 'Man the Hunted' 2New book further supports controversial theory of 'Man the Hunted' 3New book further supports controversial theory of 'Man the Hunted' 4New book further supports controversial theory of 'Man the Hunted' 5Biologists find diatom to reduce red tide's toxicity 2Biologists find diatom to reduce red tide's toxicity 3Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract 15282 1Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract 15282 2Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract 15282 3National State Front Line Caregivers Warn About 2464 Million Cut to Medicare Funding for Care of Michigan Seniors 15280 1National State Front Line Caregivers Warn About 2464 Million Cut to Medicare Funding for Care of Michigan Seniors 15280 2National State Front Line Caregivers Warn About 2464 Million Cut to Medicare Funding for Care of Michigan Seniors 15280 3National State Front Line Caregivers Warn About 2464 Million Cut to Medicare Funding for Care of Michigan Seniors 15280 4Aida Pharmaceuticals Inc Acquires High Level Research Institute in the Peoples Republic of China 4219 1Aida Pharmaceuticals Inc Acquires High Level Research Institute in the Peoples Republic of China 4219 2Aida Pharmaceuticals Inc Acquires High Level Research Institute in the Peoples Republic of China 4219 3Progen Restructures Manufacturing and Drug Discovery Divisions 4217 1Progen Restructures Manufacturing and Drug Discovery Divisions 4217 2Progen Restructures Manufacturing and Drug Discovery Divisions 4217 3
Other Contentstoxemiauseuseuseuseuseuseuseuseuseusetietietietietonsillectomytonsillectomytonsilstonsils